Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

BACKGROUND: Fatty liver is a reversible status, but also an origin stage to develop to other metabolic syndromes, such as diabetes and heart disease that threatens public health worldwide. Ascorbate deficiency is reported to be correlated with increasing risks for metabolic syndromes, but whether as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nutr Metab (Lond)
Autores principales: Xu, Yingying, Wu, Yuhang, Xiong, Yue, Tao, Jiawang, Pan, Tingcai, Tan, Shenglin, Gao, Ge, Chen, Yan, Abbas, Nasir, Getachew, Anteneh, Zhuang, Yuanqi, You, Kai, Yang, Fan, Li, Yin-xiong
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057613/
https://ncbi.nlm.nih.gov/pubmed/32158492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-020-0431-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares